Search Results

. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients . Dermatol Surg 1997 ; 23 : 929 – 933 . 66 Boyer JD Zitelli JA Brodland DG D’Angelo G . Local control of primary Merkel cell carcinoma: review of 45 cases treated

vivo tumor cellularity. Patients are evaluated for surgery 6 weeks after chemoradiotherapy. Patients with resectable disease proceed to surgery; those with unresectable disease may receive oral vorinostat once daily and oral capecitabine twice daily

, diabetes, hypertension, renal disease, liver disease, immobilization (paralysis/hemiplegia), blood clotting disorders (coagulopathy), anemia, history of VTE, history of bleeding, central venous catheter, recent sepsis, surgery, and traumatic injury were

.1%, indicating that the interventions were effective ( Table 2 ). 23 A total of 39% of patients were able to undergo bilateral nephron-sparing surgery and only 1% (n=2) became anephric; 84% of patients underwent definitive surgical treatment (partial or complete

most patients treated up to the day before surgery), and the estimated overall survival at 3 years was 84%. 15 The low response rates in this study may be a function of declaring the appropriate imaging modality or response criteria. Choi et al 16

advanced TNBC typically receive chemotherapy, surgery, and radiation therapy (RT). More recently, the concept of neoadjuvant chemotherapy (NAC) followed by surgery and RT has been introduced in women with locally advanced or palpable TNBC, 6 because TNBC

Despite continual efforts to improve prognosis and decrease treatment-related toxicities, non–small cell lung cancer (NSCLC) remains a major health epidemic worldwide. NSCLC is commonly treated with upfront surgery with or without prior induction

.5 billion, the initial phase of care (12 months) following BC diagnosis represented 37% of the cost, the continuing phase of care 41%, and the last year of life accounted for 22%. BC costs are substantially higher for the initial phase of care due to surgery

, paresthesias, and lymphedema). 1 , 2 Currently, there is sufficient evidence to support omission of completion axillary lymph node dissection (CLND) in patients undergoing breast-conserving surgery (BCS) with micrometastatic or macrometastatic disease in up to

occurrence of a pathologic complete response (pCR) after NAC. There has been some variation in how pCR has been defined in the literature, 7 but is generally defined as a lack of all signs of invasive carcinoma in tissue removed by surgery after treatment